Zantac Litigation is Born “The best starting point involves a private company known as Valisure. Valisure theorized that ranitidine [aka Zantac] has the potential to degrade into a carcinogen known as ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.

GSK targets £38 billion in sales by 2031, but market estimates fall short at £35.7 billion These cases account for 93% of the Zantac (ranitidine) lawsuits currently pending against the company.

The company has agreed to pay $2.2 billion to settle around 80,000 state court product liability cases alleging injury from Zantac (ranitidine), most of which had been consolidated in a Delaware ...

Judge Vivian Medinilla of Delaware Superior Court issued an order, which found that plaintiffs’ claims that Zantac (ranitidine) could cause multiple types of cancer were “reliable and ...

GSK plc announced that it has reached agreements with 10 plaintiff firms who together represent 93% (approximately 80,000) of the Zantac (ranitidine) state court product liability cases pending ...

The Shocking Truth" How did Zantac, once the world's most popular drug for acid reflux and heartburn, turn into a toxic ...

Zantac was pulled from shelves in 2019 amid panic that a key ingredient - ranitidine - could cause cancer, plunging GSK and several rivals into crisis. The legal wrangle had weighed on the stock ...